TRPM4 Antibody (YA7894)

TRPM4 (transient receptor potential melastatin 4) is a Ca²⁺-activated, voltage-dependent, nonselective monovalent cation channel that converts intracellular Ca²⁺ signals into membrane depolarization and thereby regulates Ca²⁺ entry through other Ca²⁺-permeable pathways^[1][2]. Mechanistically, TRPM4 activity is strongly controlled by phosphatidylinositol 4, 5-bisphosphate (PIP₂), which enhances channel Ca²⁺ sensitivity, shifts voltage dependence, and counteracts channel desensitization, linking TRPM4 to phospholipase C-associated signaling processes^[1]. Through its effects on membrane potential and Ca²⁺ homeostasis, TRPM4 participates in physiological functions including electrical signaling, immune responses, insulin secretion, and cardiovascular regulation^[2][3]. In disease contexts, altered TRPM4 function has been associated with cardiac conduction disorders and other pathophysiological conditions in which dysregulated cellular excitability contributes to disease progression^[2]. Compared with the closely related isoform TRPM5, TRPM4 shares the characteristic of being a Ca²⁺-activated monovalent cation channel but differs in tissue distribution and physiological roles, making isoform-specific interpretation important in experimental studies^[3][4]. For experimental applications, pharmacological inhibition of TRPM4 has become a useful strategy for investigating channel-dependent signaling and electrophysiological mechanisms, and several small-molecule inhibitors have been evaluated for their ability to modulate TRPM4 activity in vitro and in vivo^[5].